Gaslightwala Abizer

CIK 00020493751 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002049375

Recent Transactions

24 trades

Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+773,323→ 773,323 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+309,328→ 309,328 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase ADRs
2025-12-16+773,323→ 773,323 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase American Depositary Shares ("ADRs")
2025-12-16+309,328→ 309,328 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-08-25$0.90/sh+3,000→ 298,574 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-08-22$0.93/sh+8,000→ 295,574 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-08-21$0.94/sh+10,000→ 287,574 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-24$1.16/sh+5,203→ 277,574 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-23$1.15/sh+943→ 272,371 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-20$1.20/sh+10,000→ 271,428 total
Purchase
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-17$1.20/sh+15,000→ 261,428 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-13$1.19/sh+25,000→ 246,428 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-12$1.23/sh+20,000→ 221,428 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-06-10$1.27/sh+20,000→ 201,428 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+1,100,000→ 1,100,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+600,000→ 600,000 total
Award
Akari Therapeutics Plc$AKTX
Series A Warrants (Right to Buy)
2025-03-06$1.12/sh+133,928→ 133,928 total
Award
Akari Therapeutics Plc$AKTX
Series B Warrants (Right to Buy)
2025-03-06$1.12/sh+133,928→ 133,928 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-03-06$1.12/sh+133,928→ 181,428 total
Award
Akari Therapeutics Plc$AKTX
American Depository Shares representing Ordinary Shares
2025-01-10$1.22/sh+11,640→ 47,500 total
Award
Akari Therapeutics Plc$AKTX
American Depository Shares representing Ordinary Shares
2025-01-10$1.22/sh+11,439→ 35,860 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2025-01-03$0.00/sh+1,720,000→ 71,720,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-27$0.00/sh+40,000,000→ 70,000,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-26$0.00/sh+30,000,000→ 30,000,000 total

Companies

Akari Therapeutics Plc
Director
$AKTX

Recent Filings

Address

C/O AKARI THERAPEUTICS PLC 22 BOSTON WHARF ROAD FL 7

BOSTON, MA, 02210

View on SEC.gov